Preventive cholera vaccination resumes as global supply reaches critical milestone
First preventive campaign in over three years launches in Mozambique, with others planned in Bangladesh and the Democratic Republic of the Congo.
Gavi announces new partnerships to accelerate innovation and expand access to immunisation
New private-sector and philanthropic partnerships will help Gavi scale innovation, strengthen healthcare and reach underserved communities.
Gavi CEO calls for global health leap
Gavi CEO Dr Sania Nishtar, writing in The Lancet, sets out a framework for radical reform of global health institutions.
The Ministry of Health of the Kingdom of Cambodia announces the nationwide introduction of the rotavirus vaccine into the National Immunization Schedule, marking a significant milestone in protecting infants and young children from one of the…
UEFA, CAF and Gavi bring Goal Getters to Zimbabwe as vaccine awareness campaign grows across Africa
CAF, UEFA and Gavi, in partnership with Ministries of Health, are accelerating a pan-African movement empowering girls, countering misinformation and promoting confident, informed health choices
World Bank Group and Gavi sign a new MoU to strengthen immunisation, primary healthcare and regional vaccine manufacturing.
Board decisions place country ownership at the heart of a new operating model, reflecting key elements of the Gavi Leap transformation agenda.
Gavi and Global Polio Eradication Initiative Boards convene for second joint session
The Boards of Gavi, the Vaccine Alliance (Gavi) and the Global Polio Eradication Initiative (GPEI) convened to further strengthen collaboration and accelerate progress toward shared goals: reaching zero-dose and under-immunized children with…
Morocco pledges US$ 5 million to Gavi, debuts as a donor to global immunisation efforts
Morocco makes a donation to Gavi, pledging US$ 5 million towards its next strategic period.
Measles vaccines have contributed to dramatic reduction in cases and deaths since 2000
A new report from the World Health Organization (WHO) underscores the remarkable progress made in the fight against measles over the past 24 years.
Ethiopia has launched the national introduction of the HepB BD vaccine, marking a major step in strengthening newborn immunization and combating the transmission of Hepatitis B virus.
Deal secures more accessible future price per dose, resulting savings of up to US$ 90 million. Savings expected to help secure 30 million additional doses, protecting up to 7 million more children with malaria vaccine.